The pharmacologically delivered rIL-18 to CD2-IL-5 mice transformed naïve eosinophils to pathogenic intraepithelial eosinophilia and degranulating extracellular eosinophilic granules. This evidence concerns the gene IL5 and Increased total eosinophil count.